Railtel Q1 Results FY26: Q1 PAT Rose 35.81% to ₹66.10 Crore; Revenue Surged 33.27% YoY

Railtel Q1 Results FY26: Extracts of FY25 & FY26 (Standalone Figures)

Particulars	Quarter Ended
	30-06-2025	30-06-2024
Revenue from Operations	₹743.81	₹558.11
Profit Before Tax (PBT)	₹130.20	₹122.82
Profit After Tax (PAT)	₹66.10	₹48.67

(Figures in crores)

Railtel Results FY26 Highlights (Q1 FY26 vs FY25)

• As per the standalone figures, the quarterly PAT of Railtel has increased by 35.81% and revenue has increased by 33.27% YoY.

Railtel Share Price Performance

On the opening bell of 29th July 2025, the shares of Railtel opened at ₹338.50 per share. However, the initial gains are sustained as of now, and Railtel shares are trading at ₹379.90 per share, higher than their opening price. 

Considering the long-term performance, Railtel shares have yielded close to 21.97% returns in the past 1 year, and 5-year returns stand at 250.23%. Over the maximum timeframe, the  Railtel share provided 246.93% returns to investors. However, one must ignore the risk of volatility in the stock market and invest in Railtel shares after thorough research. 

For regular stock updates, dividend alerts, and expert verdicts, stay informed with Univest!

Disclaimer: Investment in the share market is subject to risk. This news article is for informational purposes only. Conduct your own research before investing in shares and other securities.

Also Read : CG Power Q1 Results FY26: Q1 PAT Rise 11.65% to ₹269.23 crore; Revenue Surged 29.20% YoY

Recent Articles

Adani Green Q1 Results FY26: Q1 PAT Rose 59.87% to ₹713.00 Crore; Revenue Surged 36.01% YoY

Premier Energies Q1 Results FY26: Q1 PAT Rose 55.33% to ₹307.79 Crore; Revenue Surged 9.86% YoY

Ajanta Pharma Q1 Results FY26: Q1 PAT Rose 3.89% to ₹255.34 Crore; Revenue Surged 13.78% YoY

Reliance Infrastructure Q1 Results FY26: Q1 PAT Rose 125.60% to ₹59.84 Crore; Revenue Falls 17.87% YoY

Kotak Mahindra Bank Q1 Results FY26: Q1 PAT Falls 39.96% to ₹4,472.18 Crore; Revenue Surged 6.49% YoY

B.D. Industries IPO GMP & Review: Apply or Avoid?